ArticleCureus2026
HEARTLAND Protocol: A Tiered Clinical Implementation Toolkit for Primary Care-Led Heart Failure Management in Rural and Resource-Limited Settings.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite decades of evidence-based heart failure (HF) guidelines, no published implementation protocol provides a comprehensive, operational framework for primary care-led HF management specifically designed for rural and resource-limited settings in the United States. Existing quality improvement programs, such as Get With The Guidelines-Heart Failure, identify performance targets but do not provide step-by-step clinical protocols for achieving them in settings with minimal staffing, no specialist access, and limited digital infrastructure. Established HF risk scores similarly omit rural-specific determinants of outcome, including distance to cardiology care and social support, despite robust evidence of their prognostic relevance. The HEARTLAND Protocol (Heart failure Evidence-based Access in Rural Treatment, Linking Advanced Network Delivery) addresses these gaps through a clinical implementation toolkit comprising eight integrated modules that cover the care continuum from hospital admission through long-term management. Developed through a targeted narrative review of clinical evidence published between 2018 and 2025 and informed by the Consolidated Framework for Implementation Research, the protocol synthesizes validated interventions into a tiered structure designed for deployment across varying resource levels. Key features include a three-tier implementation framework accommodating settings from severely constrained critical access hospitals to well-resourced regional centers, a dual-track system supporting both digital and analog monitoring pathways validated by the Hozhó Trial, a pharmacoeconomic generic bridge pathway ensuring that no patient remains untreated due to cost barriers, and a supplementary risk score incorporating rural-specific variables not captured by existing prognostic instruments. The protocol distinguishes between established guideline-supported evidence, emerging trial findings, and pragmatic clinical heuristics, maintaining transparency about evidence strength and methodological limitations throughout. HEARTLAND provides a practical, adaptable framework to extend evidence-based HF care to underserved communities while preserving scientific rigor and positioning facilities for emerging value-based payment models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.